Affinity Investment Advisors, Llc
Source: SEC Form 13F · as of Mar 2026Affinity Investment Advisors, Llc holds 14 biotech & pharma companies tracked by BioSniper, totaling $13.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$13.9M
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 16,149 | $2.3M |
| ABBVAbbVie Inc. | 8,935 | $1.9M |
| JNJJOHNSON & JOHNSON | 7,623 | $1.9M |
| PFEPFIZER INC | 63,312 | $1.8M |
| AMGNAMGEN INC | 4,026 | $1.4M |
| GMOptec International, Inc. | 14,815 | $1.1M |
| MRKMerck & Co., Inc. | 7,145 | $859K |
| BMYBRISTOL MYERS SQUIBB CO | 13,730 | $833K |
| PMPhilip Morris International Inc | 2,792 | $462K |
| LLYELI LILLY & Co | 360 | $331K |
| CAHCardinal Health Inc. | 1,475 | $312K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 991 | $268K |
| MCKMcKesson Corporation | 283 | $245K |
| CORCencora Inc. | 710 | $223K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.